NFE2L2 and Alzheimer disease: It is also able to induce the expression of Nrf-2 [43] and to competitively inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), a feature that is especially attractive for AD patient treatment [57].